MedTrace Logo

Observational Study for Patients With Hypertrophic Cardiomyopathy

NCT04851652 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-04-20

No results posted yet for this study

Summary

Observational study on patients with hypertrophic cardiomyopathy aims to investigate the correlation between cardiac fibrosis, as indicated by cardiac magnetic resonance, and the prognosis, and further to explore biomarkers for cardiac fibrosis and adverse prognosis of hypertrophic cardiomyopathy. Therefore, endpoints including all-cause mortality, cardiovascular death, ventricular arrythmia, non-fatal stroke, non-fatal myocardial infarction, sudden death, successful cardiopulmonary resuscitation will be evaluated.

Conditions

  • HCM - Hypertrophic Cardiomyopathy

Interventions

OTHER

No intervention nor exposure

As an observational study, no intervention nor exposure is interested.

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Cheng Huang, PhD · Guangdong Cardiovascular institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04851652 on ClinicalTrials.gov